Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Breast Neoplasms 8Neoplasms 7Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Melanoma 3Skin Neoplasms 2Neoplastic Cells, Circulating 2Lung Diseases 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2von Hippel-Lindau Disease 1Weight Loss 1Uterine Cervical Neoplasms 1Sleep Apnea Syndromes 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Ovarian Insufficiency 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Overweight 1Obesity, Morbid 1Obesity 1Nervous System Diseases 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1

Interventions

Cabergoline 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Pituitary Neoplasms × Blood Specimen Collection × Clear all
NCT03465618 2026-05-01

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
17 enrolled
CNSEndocrine

Brain Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡